Town & Country Bank & Trust CO dba First Bankers Trust CO grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,300 shares of the healthcare conglomerate’s stock after buying an additional 206 shares during the quarter. UnitedHealth Group accounts for 1.5% of Town & Country Bank & Trust CO dba First Bankers Trust CO’s portfolio, making the stock its 21st largest position. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in UnitedHealth Group were worth $3,028,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in UNH. Chelsea Counsel Co. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $27,000. 25 LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth $28,000. Cascade Investment Advisors Inc. purchased a new position in shares of UnitedHealth Group during the 1st quarter worth $28,000. Freedom Wealth Alliance LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $31,000. Finally, Kalos Management Inc. bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at $34,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.
In related news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.35% of the company’s stock.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The business had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. During the same period in the prior year, the firm earned $5.57 EPS. The company’s revenue for the quarter was up 15.6% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be paid a dividend of $1.88 per share. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 33.65%.
Wall Street Analyst Weigh In
Several brokerages have recently commented on UNH. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $564.00 to $555.00 in a research report on Monday, July 17th. Truist Financial reduced their price target on shares of UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $616.00 to $561.00 in a report on Thursday, July 13th. UBS Group lifted their price target on shares of UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a report on Wednesday, July 19th. Finally, Sanford C. Bernstein upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $595.00 to $603.00 in a report on Tuesday, July 18th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $575.65.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- 3 REITs to Buy and Hold for the Long Term
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- Technology Stocks Explained: Here’s What to Know About Tech
- 5 Reasons Mullen Automotive is About to Turn a Corner
- How to Invest in the Entertainment Industry
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.